237 related articles for article (PubMed ID: 9235677)
21. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
[TBL] [Abstract][Full Text] [Related]
22. Serum lipid profile and timolol gel.
Khamar MB; Bhatt N; Patel K
J Indian Med Assoc; 2002 Oct; 100(10):620-1. PubMed ID: 12452518
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of the beta-2 adrenoceptor and IOP lowering potency of topical timolol in healthy subjects.
Fuchsjager-Mayrl G; Markovic O; Losert D; Lucas T; Wachek V; Muller M; Schmetterer L
Mol Vis; 2005 Sep; 11():811-5. PubMed ID: 16205624
[TBL] [Abstract][Full Text] [Related]
24. Bradycardia and congestive heart failure associated with ocular timolol maleate.
Linkewich JA; Herling IM
Am J Hosp Pharm; 1981 May; 38(5):699-701. PubMed ID: 7282702
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary effects of topical timolol.
Charan NB; Lakshminarayan S
Arch Intern Med; 1980 Jun; 140(6):843-4. PubMed ID: 7387281
[TBL] [Abstract][Full Text] [Related]
26. Atishoo! Atishoo! we all fall down!
Carey BJ
Age Ageing; 2006 Jul; 35(4):446-7. PubMed ID: 16788083
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
Cimolai N
Clin Med Res; 2019 Dec; 17(3-4):90-96. PubMed ID: 31462538
[TBL] [Abstract][Full Text] [Related]
28. Timolol transport from microemulsions trapped in HEMA gels.
Li CC; Abrahamson M; Kapoor Y; Chauhan A
J Colloid Interface Sci; 2007 Nov; 315(1):297-306. PubMed ID: 17673246
[TBL] [Abstract][Full Text] [Related]
29. A cardiovascular benefit of ophthalmic beta-blockade.
Easton PJ
Age Ageing; 2007 May; 36(3):351. PubMed ID: 17405778
[No Abstract] [Full Text] [Related]
30. Topical beta-blockers and mortality.
Müskens RP; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2008 Nov; 115(11):2037-43. PubMed ID: 18801580
[TBL] [Abstract][Full Text] [Related]
31. [Adverse effects in the local treatment of glaucoma with beta-blockers].
Nielsen NV; Eriksen JS
Ugeskr Laeger; 1980 Sep; 142(36):2353-4. PubMed ID: 6108628
[No Abstract] [Full Text] [Related]
32. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers.
Valuck RJ; Perlman JI; Anderson C; Wortman GI
Pharmacoepidemiol Drug Saf; 2001; 10(6):511-6. PubMed ID: 11828833
[TBL] [Abstract][Full Text] [Related]
33. [Severe bronchial spasm crises induced by topical administration of eyedrops with timolol base, a non-selective beta blocking agent].
Confalonieri M; Aiolfi S; Patrini G; Scartabellati A; Ghio L; Mauri F; Della Porta R; Gandola L
Recenti Prog Med; 1991; 82(7-8):402-4. PubMed ID: 1947406
[TBL] [Abstract][Full Text] [Related]
34. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops.
Mullins RJ; Lones R; Dutta B
Australas J Dermatol; 2004 May; 45(2):151-2. PubMed ID: 15068470
[No Abstract] [Full Text] [Related]
35. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects.
Nieminen T; Lehtimäki T; Mäenpää J; Ropo A; Uusitalo H; Kähönen M
Scand J Clin Lab Invest; 2007; 67(2):237-45. PubMed ID: 17366003
[TBL] [Abstract][Full Text] [Related]
36. Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report.
Minish T; Herd A
J Emerg Med; 2002 Apr; 22(3):247-9. PubMed ID: 11932086
[TBL] [Abstract][Full Text] [Related]
37. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
Patane' S; Marte F; Di Bella G; Pugliatti P
Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438
[No Abstract] [Full Text] [Related]
39. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
Good CB
Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
[No Abstract] [Full Text] [Related]
40. Current use of ophthalmic beta blockers.
Gross RL; Pineyro A
J Glaucoma; 1997 Jun; 6(3):188-91. PubMed ID: 9211143
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
